Sofgen Pharma S.A.
SEC CIK 1863362 · PROC · last insider filing 2026-03-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Moreira Muniz Fernando Sebastian | Director | filed 2026 - 2026 |
| Garcia Iragorri Carlos | Director | filed 2026 - 2026 |
| Eguiguren Alberto | Director | filed 2026 - 2026 |
| Bernal Jaramillo Daniel Augusto | Director | filed 2026 - 2026 |
| Vial Claro Manuel Jose | Director | filed 2026 - 2026 |
| Romero Camacho Carlos | Director | filed 2026 - 2026 |
| Manieu Alexandre Weinstein | Director | filed 2021 - 2026 |
| Weinstein Nicolas Alexandre | Director | filed 2026 - 2026 |
| Minski Ruben | Director · Chief Executive Officer | filed 2021 - 2021 |
| Minski Jose | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Palacios Luis Alberto | Chief Commercial Officer | filed 2026 - 2026 |
| Silva Angelini Melissa Andreia | Interim CEO | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.